Eremophila freelingii
Eremophila freelingii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Eremophila freelingii is a unique botanical species often utilized in traditional medicinal practices. When addressing the discomfort of a headache, this plant can serve as a valuable natural resource. Practitioners frequently utilize specific extracts to harness its potent therapeutic properties. These concentrated preparations allow for more efficient delivery of the plant's active compounds. Understanding its application provides insight into the diverse uses of this remarkable flora.
- Synonyms
- Bondtia Freelingii
- Common names
- Not available
- Family
- Scrophulariaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Eremophila freelingii is a distinctive plant that is widely recognized by several different names across various cultures. It is most commonly known in English as the Limestone Fuchsia, a name that highlights its unique botanical characteristics. In certain local contexts, the species is also affectionately referred to as miinypa. Furthermore, the plant holds a place in linguistic diversity through its Chinese designation, 吊鐘喜沙. Understanding these various names helps enthusiasts identify this special species regardless of the terminology used.
Sources: Catalogue of Life (COL)
Synonyms
Eremophila freelingii is a distinctive botanical species that is sometimes identified by its synonym, Bondtia freelingii. This taxonomic connection highlights the evolving classification of the plant within its genus. Understanding these nomenclatural shifts is essential for researchers tracking the plant's evolutionary history. By recognizing both names, botanists can ensure accuracy when documenting its specific habitat and characteristics. Consequently, maintaining this relationship between names provides a clearer picture of the species' place in the natural world.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Eremophila freelingii belongs to the diverse kingdom Plantae, representing a unique branch of the natural world. Within this vast group, the species is classified under the class Equisetopsida. It further resides in the order Lamiales, a lineage that connects it to various other flowering plants. As a member of the family Scrophulariaceae, it shares specific botanical characteristics with its relatives. Ultimately, this plant is defined by its placement within the specialized genus Eremophila.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Scrophulariaceae |
| Genus | Eremophila |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Eremophila freelingii is a resilient species with a broad geographic presence across the Australasia region. Its native range is primarily concentrated within Australia, where it adapts to various diverse environments. Specifically, this plant can be found flourishing in the states of New South Wales and the Northern Territory. It also maintains significant populations throughout Queensland and South Australia. Furthermore, its distribution extends westward into the rugged landscapes of Western Australia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Eremophila freelingii is a self-supporting shrub that maintains a sturdy structural form. This resilient plant typically reaches a maximum height of 2 meters as it matures. Its compact growth habit allows it to thrive within its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Eremophila freelingii is utilized traditionally as a treatment for headaches. Scientific screening of its extracts has demonstrated a potent ability to inhibit ADP-induced human platelet 5-HT release in vitro. This inhibition occurs at significant levels, ranging between 62% and 95% during laboratory testing. Such biological activity suggests the plant contains specific constituents capable of affecting platelet function related to migraine therapeutics. Further research is required to identify the exact compounds and mechanisms responsible for these medicinal effects.
Preparations
Eremophila freelingii is prepared as extracts for the purpose of investigating potential migraine therapeutics. These specific extracts were screened to identify plant constituents that might affect ADP-induced platelet aggregation and 5-HT release. Scientific analysis demonstrated that the extracts from this plant significantly inhibit human platelet [14C]-5-hydroxytryptamine release in vitro. This inhibitory effect remained potent even after the removal of polyphenolic tannins through the use of polyvinyl pyrrolidone. The study highlights how these prepared extracts serve as a key component in researching traditional headache treatments.